S3-Leitlinie Prostatakarzinom - AWMF

9. Literatur
269. Bria E, Cuppone F, Giannarelli D, Milella M, Ruggeri EM, Sperduti I, Pinnaro P, Terzoli E,
Cognetti F, Carlini P. Does hormone treatment added to radiotherapy improve outcome in
locally advanced prostate cancer?: meta-analysis of randomized trials. Cancer
2009;115(15):3446-56. http://www.ncbi.nlm.nih.gov/pubmed/19484790
270. Zelefsky MJ, Chan H, Hunt M, Yamada Y, Shippy AM, Amols H. Long-term outcome of high
dose intensity modulated radiation therapy for patients with clinically localized prostate
cancer. J Urol 2006;176(4 Pt 1):1415-9. http://www.ncbi.nlm.nih.gov/pubmed/16952647
271. Al-Mamgani A, van Putten WL, Heemsbergen WD, van Leenders GJ, Slot A, Dielwart MF,
Incrocci L, Lebesque JV. Update of Dutch multicenter dose-escalation trial of radiotherapy
for localized prostate cancer. Int J Radiat Oncol Biol Phys 2008;72(4):980-8.
http://www.ncbi.nlm.nih.gov/pubmed/18495377
272. Pilepich MV, Krall JM, Johnson RJ, Sause WT, Perez CA, Zinninger M, Martz K. Extended field
(periaortic) irradiation in carcinoma of the prostate--analysis of RTOG 75-06. Int J Radiat
Oncol Biol Phys 1986;12(3):345-51. http://www.ncbi.nlm.nih.gov/pubmed/3514555
273. Asbell SO, Martz KL, Shin KH, Sause WT, Doggett RL, Perez CA, Pilepich MV. Impact of
surgical staging in evaluating the radiotherapeutic outcome in RTOG #77-06, a phase III
study for T1BN0M0 (A2) and T2N0M0 (B) prostate carcinoma. Int J Radiat Oncol Biol Phys
1998;40(4):769-82. http://www.ncbi.nlm.nih.gov/pubmed/9531360
274. Deger S, Boehmer D, Turk I, Roigas J, Wernecke KD, Wiegel T, Hinkelbein W, Dinges S,
Budach V, Loening SA. High dose rate brachytherapy of localized prostate cancer. Eur Urol
2002;41(4):420-6. http://www.ncbi.nlm.nih.gov/pubmed/12074814
275. Kalkner KM, Wahlgren T, Ryberg M, Cohn-Cedermark G, Castellanos E, Zimmerman R,
Nilsson J, Lundell M, Fowler J, Levitt S, Hellstrom M, Nilsson S. Clinical outcome in patients
with prostate cancer treated with external beam radiotherapy and high dose-rate iridium
192 brachytherapy boost: a 6-year follow-up. Acta Oncol 2007;46(7):909-17.
http://www.ncbi.nlm.nih.gov/pubmed/17917823
276. Heidenreich A, Varga Z, von Knobloch R. Extended pelvic lymphadenectomy in patients
undergoing radical prostatectomy: high incidence of lymph node metastasis. Journal of
Urology 2002;167(4):1681-6. http://www.ncbi.nlm.nih.gov/pubmed/11912387
277. Stone NN, Stock RG, Unger P. Laparoscopic pelvic lymph node dissection for prostate
cancer: comparison of the extended and modified techniques. J Urol 1997;158(5):1891-4.
http://www.ncbi.nlm.nih.gov/pubmed/9334624
278. Shelley M, Wilt TJ, Coles B, Mason MD. Cryotherapy for localised prostate cancer. Cochrane
Database Syst Rev 2007;(3):CD005010. http://www.ncbi.nlm.nih.gov/pubmed/17636783
279. Chin JL, Ng CK, Touma NJ, Pus NJ, Hardie R, Abdelhady M, Rodrigues G, Radwan J,
Venkatesan V, Moussa M, Downey DB, Bauman G. Randomized trial comparing cryoablation
and external beam radiotherapy for T2C-T3B prostate cancer. Prostate Cancer Prostatic Dis
2008;11(1):40-5. http://www.ncbi.nlm.nih.gov/pubmed/17579613
280. Cohen JK, Miller RJ, Jr., Ahmed S, Lotz MJ, Baust J. Ten-year biochemical disease control for
patients with prostate cancer treated with cryosurgery as primary therapy. Urology
2008;71(3):515-8. http://www.ncbi.nlm.nih.gov/pubmed/18342200
281. Tilly W, Gellermann J, Graf R, Hildebrandt B, Weissbach L, Budach V, Felix R, Wust P.
Regional hyperthermia in conjunction with definitive radiotherapy against recurrent or
locally advanced prostate cancer T3 pN0 M0. Strahlenther Onkol 2005;181(1):35-41.
http://www.ncbi.nlm.nih.gov/pubmed/15660191
282. Maluta S, Dall'Oglio S, Romano M, Marciai N, Pioli F, Giri MG, Benecchi PL, Comunale L,
Porcaro AB. Conformal radiotherapy plus local hyperthermia in patients affected by locally
© Leitlinienprogramm Onkologie | S3-Leitlinie Prostatakarzinom | Version 2.0, 1. Aktualisierung 2011